Trade ALXO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ALX Oncology Holdings Inc. (ALXO) is trading at US$1.70, down 2.30% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$282.09M. Over the past 52 weeks, ALXO has traded between US$1.05 and US$2.66. On Syfe you can trade ALXO with $0 commission and add it to your watchlist.
| Previous close | US$1.74 |
|---|---|
| Market cap | US$282.09M |
| 52-week range | US$1.05 – US$2.66 |
| Volume | 5.06M |
| Exchange | US |
Add to Watchlist
Set Price Alert
ALX Oncology Holdings Inc.
ALX Oncology Holdings, Inc. is a clinical-stage biotechnology company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Year: 2020
ALX Oncology Appoints Scott Garland as Board Chairman
Jun 30, 12:23 PM · MT Newswires
ALX Oncology Names Jeff Knight Chief Development, Operating Officer
Apr 13, 2:17 PM · MT Newswires
ALX Oncology Holdings Inc. (ALXO) stock is trading at US$1.70, -2.30% from the previous close of US$1.74.
The market cap for ALX Oncology Holdings Inc. (ALXO) stock is approximately US$282.09M.
The 52-week high for ALX Oncology Holdings Inc. (ALXO) stock is US$2.66.
The 52-week low for ALX Oncology Holdings Inc. (ALXO) stock is US$1.05.
ALX Oncology Holdings Inc. (ALXO) does not currently pay a dividend.
Stay on top of ALXO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
